Compounds > ellipticine

ellipticine and phosphorus radioisotopes

ellipticine has been researched along with phosphorus radioisotopes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlt, VM; Bieler, CA; Frei, E; Stiborová, M; Wiessler, M1
Borek-Dohalská, L; Frei, E; Stiborová, M; Stiborová-Rupertová, M; Wiessler, M1
Aimová, D; Breuer, A; Frei, E; Stiborová, M; Stiborová-Rupertová, M; Wiessler, M1
Arlt, VM; Frei, E; Henderson, CJ; Hudecek, J; Kotrbová, V; Moserová, M; Phillips, DH; Stiborová, M; Wolf, CR1
Dontenwill, M; Frei, E; Martinkova, E; Stiborova, M1
Eckschlager, T; Frei, E; Kizek, R; Poljakova, J; Stiborova, M1

Other Studies

6 other study(ies) available for ellipticine and phosphorus radioisotopes

ArticleYear
Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes.
    Biochemical pharmacology, 2002, Jul-15, Volume: 64, Issue:2

    Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line; Cells, Cultured; Cricetinae; Cytochrome P-450 Enzyme System; DNA; DNA Adducts; Ellipticines; Humans; Phosphorus Radioisotopes; Transfection

2002
Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans.
    Chemical research in toxicology, 2003, Volume: 16, Issue:1

    Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deoxyguanosine; DNA; DNA Adducts; Ellipticines; Enzyme Inhibitors; Humans; Isoenzymes; Microsomes, Liver; Models, Animal; Phosphorus Radioisotopes; Rabbits; Rats; Species Specificity

2003
DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P postlabeling.
    International journal of cancer, 2003, Dec-20, Volume: 107, Issue:6

    Topics: Animals; Antineoplastic Agents; Biotransformation; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; DNA Adducts; Ellipticines; Isotope Labeling; Male; Microsomes; Microsomes, Liver; Organ Specificity; Phosphorus Radioisotopes; Rats; Rats, Wistar; Tissue Distribution

2003
Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse.
    Toxicology and applied pharmacology, 2008, Feb-01, Volume: 226, Issue:3

    Topics: Animals; Antineoplastic Agents; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP3A; DNA; DNA Adducts; Dose-Response Relationship, Drug; Ellipticines; Gene Silencing; Hepatocytes; Injections, Intraperitoneal; Isotope Labeling; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Phosphorus Radioisotopes

2008
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells.
    Neuro endocrinology letters, 2009, Volume: 30 Suppl 1

    Topics: Antineoplastic Agents; Autoradiography; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; DNA Adducts; Dose-Response Relationship, Drug; Ellipticines; Glioblastoma; Humans; Phosphorus Radioisotopes; Polymerase Chain Reaction; RNA, Messenger

2009
Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the ³²P-postlabeling technique.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2012, Volume: 156, Issue:2

    Topics: Antineoplastic Agents; Cell Line, Tumor; DNA Adducts; Doxorubicin; Ellipticines; Humans; Isotope Labeling; Neuroblastoma; Phosphorus Radioisotopes

2012